The MFE110 successfully produced separated hydrogen and oxygen at the pre-determined specifications for commercial deployment, confirming the first customer acceptance and validation of CPH2's scaled electrolyser technology. The test also validates CPH2's membrane-free technology as a viable and potentially highly competitive alternative to PEM and Alkaline electrolysers.
The next stage is the deployment of the MFE 110 unit to Northern Ireland Water's site for installation leading to commercial hydrogen and oxygen production.
The final stage of the FAT for the MFE110 involved successfully verifying the safe and fully automated startup, operation, performance, and shutdown of the MFE110 unit to the pre-determined specification. During this operation, key metrics such as the unit’s hydrogen and oxygen output pressure, flow rate, and purity levels were recorded. All metrics achieved the necessary thresholds, confirming that the unit can function effectively.
The Level 3 test was witnessed by both Arup and Lagan MEICA and followed successful pre-commissioning checks (Level 1) and functional tests (Level 2). The MFE110 will now be shipped to Northern Ireland Water for site installation, integration, and commissioning, before commencing commercial hydrogen and oxygen production.
This marks the most significant milestone in CPH2's journey to market, validating its Membrane-Free Technology as a viable alternative to PEM and Alkaline electrolysers. It also represents a crucial step forward for the MFE220, CPH2’s flagship 1MW design.
Capitalising on the successful MFE110 FAT, the Company will not turn to a phase of Commerciality, where the focus moves from product development to commercialisation. The Commerciality Phase will see the company delivering on its existing three customer contracts for MFE220 units; activating the licensees and supporting them; continued technology and product improvement; and growing the commercial pipeline.
The deliverables through the Commerciality Phase will be revenue generating, commercial MFE220 electrolysers working on customer sites and licensees commencing manufacturing. The capabilities developed and activities undertaken over the Commerciality Phase are expected to provide valuable learnings in preparation for scaling commercial activities.
“The successful FAT of our MFE110 electrolyser marks the most significant milestone in CPH2’s history to date” said Jon Duffy, CEO of CPH2. “Our new, low cost and highly robust technology solution is proven. This achievement is a true testament to our unwavering commitment to innovation, quality, and safety, and positions us strongly for the next phase of our journey. The completed FAT is the culmination of many hours of hard work and determination from our entire team. I want to extend my deepest gratitude to our dedicated team, supportive shareholders, Northern Ireland Water, and to Lagan MEICA for their support throughout this process. The process that CPH2 to reach this point has seen us overcome unexpected technological and engineering hurdles but has meant a stepped improvement in the product offering including significantly enhanced safety to industry recognised SIL ratings and fully automatic operation, control and shutdown. There is a renewed confidence in the capability of our technology to address the significant market opportunity. We will now turn our attention to the commercial roll-out and delivering the MFE220 through our own manufacture and of our license holders.”
For additional information:
